154 related articles for article (PubMed ID: 24573123)
61. Evidence-based surgical management of T1 or T2 temporal bone malignancies.
Zhang T; Li W; Dai C; Chi F; Wang S; Wang Z
Laryngoscope; 2013 Jan; 123(1):244-8. PubMed ID: 23008138
[TBL] [Abstract][Full Text] [Related]
62. Neck dissection for squamous cell carcinoma of the head and neck.
Santa Maria PL; Sader C; Preston NJ; Fisher PH
Otolaryngol Head Neck Surg; 2007 Apr; 136(4 Suppl):S41-5. PubMed ID: 17398340
[TBL] [Abstract][Full Text] [Related]
63. Hemimandibulectomy and therapeutic neck dissection with radiotherapy in the treatment of oral squamous cell carcinoma involving mandible: a critical review of treatment protocol in the years 1994-2004.
Hoffmannová J; Foltán R; Vlk M; Sipos M; Horká E; Pavlíková G; Kufa R; Bulík O; Sedý J
Int J Oral Maxillofac Surg; 2010 Jun; 39(6):561-7. PubMed ID: 20418065
[TBL] [Abstract][Full Text] [Related]
64. Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management.
Arya S; Rane P; Deshmukh A
Clin Radiol; 2014 Sep; 69(9):916-30. PubMed ID: 24908285
[TBL] [Abstract][Full Text] [Related]
65. Incidence of osteoradionecrosis of the temporal bone.
Morrissey D; Grigg R
ANZ J Surg; 2011 Dec; 81(12):876-9. PubMed ID: 22507412
[TBL] [Abstract][Full Text] [Related]
66. [Current status of the diagnosis and treatment of temporal bone squamous cell carcinoma].
Xiao L; Liu A; Ma H; Jiang H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 36(7):559-565. PubMed ID: 35822388
[No Abstract] [Full Text] [Related]
67. Roles of epithelial-mesenchymal transition in squamous cell carcinoma of the temporal bone.
Sugimoto H; Ito M; Hatano M; Kondo S; Suzuki S; Yoshizaki T
Otol Neurotol; 2011 Apr; 32(3):483-7. PubMed ID: 21358455
[TBL] [Abstract][Full Text] [Related]
68. The outcome of radical surgery and postoperative radiotherapy for squamous carcinoma of the temporal bone.
Moffat DA; Wagstaff SA; Hardy DG
Laryngoscope; 2005 Feb; 115(2):341-7. PubMed ID: 15689763
[TBL] [Abstract][Full Text] [Related]
69. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
[TBL] [Abstract][Full Text] [Related]
70. Squamous cell carcinoma of the oropharynx and hypopharynx.
Lin DT; Cohen SM; Coppit GL; Burkey BB
Otolaryngol Clin North Am; 2005 Feb; 38(1):59-74, viii. PubMed ID: 15649499
[TBL] [Abstract][Full Text] [Related]
71. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
[TBL] [Abstract][Full Text] [Related]
72. Therapeutic selective neck dissection: a 25-year review.
Muzaffar K
Laryngoscope; 2003 Sep; 113(9):1460-5. PubMed ID: 12972914
[TBL] [Abstract][Full Text] [Related]
73. Squamous cell carcinoma of the temporal bone: clinical outcomes from radical surgery and postoperative radiotherapy.
Masterson L; Rouhani M; Donnelly NP; Tysome JR; Patel P; Jefferies SJ; Roques T; Scrase C; Mannion R; Macfarlane R; Hardy D; Durrani A; Price R; Marker A; Axon P; Moffat DA
Otol Neurotol; 2014 Mar; 35(3):501-8. PubMed ID: 24492135
[TBL] [Abstract][Full Text] [Related]
74. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma.
Cannady SB; Lee WT; Scharpf J; Lorenz RR; Wood BG; Strome M; Lavertu P; Esclamado RM; Saxton JP; Adelstein DJ
Head Neck; 2010 Mar; 32(3):348-56. PubMed ID: 19672875
[TBL] [Abstract][Full Text] [Related]
75. Temporal bone management in external and middle ear carcinoma.
Gowrishankar S; Borsetto D; Marinelli J; Panizza B
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):138-142. PubMed ID: 38193562
[TBL] [Abstract][Full Text] [Related]
76. Pathology of secondary malignant tumors of the temporal bone.
Schuknecht HF; Allam AF; Murakami Y
Ann Otol Rhinol Laryngol; 1968 Feb; 77(1):5-22. PubMed ID: 5645142
[No Abstract] [Full Text] [Related]
77. Temporal bone carcinoma: Novel prognostic score based on clinical and histological features.
Zanoletti E; Franz L; Cazzador D; Franchella S; Calvanese L; Nicolai P; Mazzoni A; Marioni G
Head Neck; 2020 Dec; 42(12):3693-3701. PubMed ID: 32851728
[TBL] [Abstract][Full Text] [Related]
78. Isolated squamous cell carcinoma of the tympanic membrane.
Somers T; Vercruysse JP; Goovaerts G; Govaerts P; Offeciers E
Otol Neurotol; 2002 Sep; 23(5):808. PubMed ID: 12218640
[No Abstract] [Full Text] [Related]
79. Malignancy of the temporal bone.
Leonetti JP; Marzo SJ
Otolaryngol Clin North Am; 2002 Apr; 35(2):405-10. PubMed ID: 12391626
[TBL] [Abstract][Full Text] [Related]
80. Squamous cell carcinoma of the temporal bone: A current review.
Lovin BD; Gidley PW
Laryngoscope Investig Otolaryngol; 2019 Dec; 4(6):684-692. PubMed ID: 31890889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
